A novel dual-mode and label-free aptasensor based methodology for breast cancer tissue marker targeting

[1]  M. Ganjali,et al.  A colorimetric paper sensor for citrate as biomarker for early stage detection of prostate cancer based on peroxidase-like activity of cysteine-capped gold nanoclusters. , 2019, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[2]  M. Ganjali,et al.  Oxidase-like Catalytic activity of Cys-AuNCs upon visible light irradiation and its application for visual miRNA detection , 2018, Sensors and Actuators B: Chemical.

[3]  M. Ganjali,et al.  Visual detection of miRNA using peroxidase-like catalytic activity of DNA-CuNCs and methylene blue as indicator. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[4]  M. Ganjali,et al.  Detection of large deletion in human BRCA1 gene in human breast carcinoma MCF-7 cells by using DNA-Silver Nanoclusters , 2017, Methods and applications in fluorescence.

[5]  Minghui Yang,et al.  A copper based enzyme-free fluorescence ELISA for HER2 detection. , 2017, Journal of immunological methods.

[6]  M. Ganjali,et al.  Fluorometric determination of microRNA via FRET between silver nanoclusters and CdTe quantum dots , 2017, Microchimica Acta.

[7]  B. Shao,et al.  Peptide-Functionalized Nanomaterials for the Efficient Isolation of HER2-Positive Circulating Tumor Cells. , 2017, ACS applied materials & interfaces.

[8]  Mohammad Reza Ganjali,et al.  Fluorescence based turn-on strategy for determination of microRNA-155 using DNA-templated copper nanoclusters , 2017, Microchimica Acta.

[9]  M. Hosseini,et al.  A new fluorescence turn-on nanobiosensor for the detection of micro-RNA-21 based on a DNA–gold nanocluster , 2017, Methods and applications in fluorescence.

[10]  U. Bora,et al.  Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas , 2017, Clinical and Translational Oncology.

[11]  D. Auguste,et al.  Incorporating gold nanoclusters and target-directed liposomes as a synergistic amplified colorimetric sensor for HER2-positive breast cancer cell detection , 2017, Theranostics.

[12]  Xiaoyuan Chen,et al.  Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer. , 2017, Bioconjugate chemistry.

[13]  Soo-young Park,et al.  In vitro detection of human breast cancer cells (SK-BR3) using herceptin-conjugated liquid crystal microdroplets as a sensing platform. , 2016, Biomaterials science.

[14]  A. Luxen,et al.  Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer , 2016, Pharmaceuticals.

[15]  Yasar Gurbuz,et al.  Label-free capacitance based aptasensor platform for the detection of HER2/ErbB2 cancer biomarker in serum , 2015 .

[16]  S. Karna,et al.  Nature of Interaction between Semiconducting Nanostructures and Biomolecules: Chalcogenide QDs and BNNT with DNA Molecules , 2015 .

[17]  Zhiyuan Hu,et al.  Microarray based screening of peptide nano probes for HER2 positive tumor. , 2015, Analytical chemistry.

[18]  Juewen Liu,et al.  DNA-templated fluorescent gold nanoclusters reduced by Good's buffer: from blue-emitting seeds to red and near infrared emitters , 2015 .

[19]  S. Maier,et al.  Highly sensitive single domain antibody-quantum dot conjugates for detection of HER2 biomarker in lung and breast cancer cells. , 2014, ACS nano.

[20]  Peisheng Xu,et al.  Redox Potential Ultrasensitive Nanoparticle for the Targeted Delivery of Camptothecin to HER2-Positive Cancer Cells , 2014, Molecular pharmaceutics.

[21]  W. Cai,et al.  Antibody-based imaging of HER-2: moving into the clinic. , 2013, Current molecular medicine.

[22]  Jonathan D. Ashley,et al.  A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. , 2013, ACS nano.

[23]  K. Yavari,et al.  Optimized preparation and preliminary evaluation of [64Cu]–DOTA–trastuzumab for targeting ErbB2/Neu expression , 2013, Journal of Radioanalytical and Nuclear Chemistry.

[24]  Yong-mei Song,et al.  Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro , 2012, Journal of Translational Medicine.

[25]  Alfonso Latorre,et al.  DNA‐Mediated Silver Nanoclusters: Synthesis, Properties and Applications , 2012, Chembiochem : a European journal of chemical biology.

[26]  Kimberly S Butler,et al.  Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. , 2012, Contrast media & molecular imaging.

[27]  Seonghwan Lee,et al.  Aptamers and Their Biological Applications , 2012, Sensors.

[28]  W Cai,et al.  Aptamers as therapeutics in cardiovascular diseases. , 2011, Current medicinal chemistry.

[29]  H. Dehghani,et al.  Generation of an enriched pool of DNA aptamers for an HER2‐overexpressing cell line selected by Cell SELEX , 2011, Biotechnology and applied biochemistry.

[30]  Sunjoo Jeong,et al.  In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells. , 2011, Nucleic acid therapeutics.

[31]  S. Akhlaghpoor,et al.  MRI contrast agent for molecular imaging of the HER2/neu receptor using targeted magnetic nanoparticles , 2011 .

[32]  W. Tseng,et al.  Ultrasensitive sensing of Hg(2+) and CH(3)Hg(+) based on the fluorescence quenching of lysozyme type VI-stabilized gold nanoclusters. , 2010, Analytical chemistry.

[33]  Wanyi Tai,et al.  The role of HER2 in cancer therapy and targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Sadia Afrin Khan,et al.  Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay. , 2010, ACS nano.

[35]  Juewen Liu,et al.  Functional nucleic acid sensors. , 2009, Chemical reviews.

[36]  S. S. Sinha,et al.  Ultrafast energy transfer from 3-mercaptopropionic acid-capped CdSe/ZnS QDs to dye-labelled DNA , 2008 .

[37]  Qiao Xu,et al.  Interaction of CdTe quantum dots with DNA , 2008 .

[38]  Gillian C. Lynch,et al.  Quantum dot-DNA interaction: Computational issues and preliminary insights on use of quantum dots as biosensors , 2008 .

[39]  R. Cavicchi,et al.  Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells , 2008, BMC Cancer.

[40]  Eva M. Sevick-Muraca,et al.  Dual-Labeled Trastuzumab-Based Imaging Agent for the Detection of Human Epidermal Growth Factor Receptor 2 Overexpression in Breast Cancer , 2007, Journal of Nuclear Medicine.

[41]  U. Krull,et al.  Adsorption and hybridization of oligonucleotides on mercaptoacetic acid-capped CdSe/ZnS quantum dots and quantum dot-oligonucleotide conjugates. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[42]  M. Ganjali,et al.  Copper nanocluster-enhanced luminol chemiluminescence for high-selectivity sensing of tryptophan and phenylalanine. , 2017, Luminescence : the journal of biological and chemical luminescence.

[43]  Zhiyuan Hu,et al.  Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide. , 2017, Biomaterials.

[44]  A. González-Angulo,et al.  Advances and Future Directions in the Targeting of HER2-positive Breast Cancer: Implications for the Future , 2013, Current Treatment Options in Oncology.

[45]  Carolina Gutierrez,et al.  HER2: biology, detection, and clinical implications. , 2011, Archives of pathology & laboratory medicine.